Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass

Clinical Science

Volumn 128, Issue 2, 2015, Pages 131-142

  Uc, Aliye ^a   Olivier, Alicia K ^a   Griffin, Michelle A ^a   Meyerholz, David K ^a   Yao, Jianrong ^a   Abu El Haija, Maisam ^b   Buchanan, Katherine M ^a   Vanegas Calderón, Oriana G ^a   Abu El Haija, Marwa ^c   Pezzulo, Alejandro A ^a   Reznikov, Leah R ^a   Hoegger, Mark J ^a   Rector, Michael V ^a   Ostedgaard, Lynda S ^a   Taft, Peter J ^a   Gansemer, Nick D ^a   Ludwig, Paula S ^a   Hornick, Emma E ^a   Stoltz, David A ^a   Ode, Katie L ^a   Welsh, Michael J ^a,d   Engelhardt, John F ^a   Norris, Andrew W ^a   more..

^a UNIVERSITY OF IOWA   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Cystic fibrosis related diabetes; Exocrine pancreas; Glucagon; Glucose tolerance test; Pancreas; Pig

Indexed keywords

GLUCAGON; INSULIN; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOCRINE PANCREAS; EXPERIMENTAL PIG; FETUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; NEWBORN; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; ANIMAL; BLOOD; COMPLICATION; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; METABOLISM; PANCREAS; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; PIG; SECRETION (PROCESS);

ANIMALS; BLOOD GLUCOSE; CYSTIC FIBROSIS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN; ISLETS OF LANGERHANS; PANCREAS; SWINE;

EID: 84921454227     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140059     Document Type: Article

References (71)

1. Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N. and Chou, J. L. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073
2. Rommens, J. M., Iannuzzi, M. C., Kerem, B., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D. and Hidaka, N. (1989) Identification of the cystic fibrosis gene:chromosome walking and jumping. Science 245, 1059-1065
3. Welsh, M. J., Ramsey, B. W., Accurso, F. J. and Cutting, G. R. (2001) Cystic fibrosis. In The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D., eds), p. 5121, McGraw-Hill, New York
4. Quinton, P. M. (2007) Cystic fibrosis: lessons from the sweat gland. Physiology (Bethesda). 22, 212-225
5. Wilschanski, M. and Durie, P. R. (2007) Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 56, 1153-1163
6. Borowitz, D., Durie, P. R., Clarke, L. L., Werlin, S. L., Taylor, C. J., Semler, J., De Lisle, R. C., Lewindon, P., Lichtman, S. M., Sinaasappel, M. et al. (2005) Gastrointestinal outcomes and confounders in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 41, 273-285
7. Andersen, D. H. (1938) Cystic fibrosis of the pancreas and its relation to celiac disease: clinical and pathological study. Am. J. Dis. Child. 56, 344-399
8. Oppenheimer, E. H. and Esterly, J. R. (1975) Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. Perspect. Pediatr. Pathol. 2, 241-278
9. Corey, M., Edwards, L., Levison, H. and Knowles, M. (1997) Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J. Pediatr. 131, 809-814
10. Konstan, M. W., Butler, S. M., Wohl, M. E., Stoddard, M., Matousek, R., Wagener, J. S., Johnson, C. A. and Morgan, W. J. (2003) Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J. Pediatr. 142, 624-630
11. Gaskin, K., Gurwitz, D., Durie, P., Corey, M., Levison, H. and Forstner, G. (1982) Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J. Pediatr. 100, 857-862
12. Kraemer, R., Rudeberg, A., Hadorn, B. and Rossi, E. (1978) Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr. Scand. 67, 33-37
13. Dodge, J. A., Lewis, P. A., Stanton, M. and Wilsher, J. (2007) Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur. Respir. J. 29, 522-526
14. Moran, A., Dunitz, J., Nathan, B., Saeed, A., Holme, B. and Thomas, W. (2009) Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 32, 1626-1631
15. Stecenko, A. A. and Moran, A. (2010) Update on cystic fibrosis-related diabetes. Curr. Opin. Pulm. Med. 16, 611-615
16. Milla, C. E., Warwick, W. J. and Moran, A. (2000) Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am. J. Respir. Crit. Care Med. 162, 891-895
17. Chamnan, P., Shine, B. S., Haworth, C. S., Bilton, D. and Adler, A. I. (2010) Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 33, 311-316
18. Nathan, B. M., Laguna, T. and Moran, A. (2010) Recent trends in cystic fibrosis-related diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 17, 335-341
19. Moran, A., Diem, P., Klein, D. J., Levitt, M. D. and Robertson, R. P. (1991) Pancreatic endocrine function in cystic fibrosis. J. Pediatr. 118, 715-723
20. Moran, A., Phillips, J. and Milla, C. (2001) Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 24, 1706-1710
21. Mohan, K., Miller, H., Dyce, P., Grainger, R., Hughes, R., Vora, J., Ledson, M. and Walshaw, M. (2009) Mechanisms of glucose intolerance in cystic fibrosis. Diabet. Med. 26, 582-588
22. Hamdi, I., Green, M., Shneerson, J. M., Palmer, C. R. and Hales, C. N. (1993) Proinsulin, proinsulin intermediate and insulin in cystic fibrosis. Clin. Endocrinol. (Oxf.) 39, 21-26
23. Ripa, P., Robertson, I., Cowley, D., Harris, M., Masters, I. B. and Cotterill, A. M. (2002) The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis. Clin. Endocrinol. (Oxf.) 56, 383-389
24. Lanng, S., Thorsteinsson, B., Roder, M. E., Orskov, C., Holst, J. J., Nerup, J. and Koch, C. (1993) Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol. (Copenh.) 128, 207-214
25. Lohr, M., Goertchen, P., Nizze, H., Gould, N. S., Gould, V. E., Oberholzer, M., Heitz, P. U. and Kloppel, G. (1989) Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch. A Pathol. Anat. Histopathol. 414, 179-185
26. Abdul-Karim, F. W., Dahms, B. B., Velasco, M. E. and Rodman, H. M. (1986) Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study. Arch. Pathol. Lab. Med. 110, 602-606
27. Iannucci, A., Mukai, K., Johnson, D. and Burke, B. (1984) Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum. Pathol. 15, 278-284
28. Soejima, K. and Landing, B. H. (1986) Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus:morphometric and immunocytologic studies. Pediatr. Pathol. 6, 25-46
29. Rogers, C. S., Stoltz, D. A., Meyerholz, D. K., Ostedgaard, L. S., Rokhlina, T., Taft, P. J., Rogan, M. P., Pezzulo, A. A., Karp, P. H., Itani, O. A. et al. (2008) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837-1841
30. Ostedgaard, L. S., Meyerholz, D. K., Chen, J. H., Pezzulo, A. A., Karp, P. H., Rokhlina, T., Ernst, S. E., Hanfland, R. A., Reznikov, L. R., Ludwig, P. S. et al. (2011) The DeltaF508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci. Transl. Med. 3, 74ra24
31. Meyerholz, D. K., Stoltz, D. A., Pezzulo, A. A. and Welsh, M. J. (2010) Pathology of gastrointestinal organs in a porcine model of cystic fibrosis. Am. J. Pathol. 176, 1377-1389
32. Stoltz, D. A., Meyerholz, D. K., Pezzulo, A. A., Ramachandran, S., Rogan, M. P., Davis, G. J., Hanfland, R. A., Wohlford-Lenane, C., Dohrn, C. L., Bartlett, J. A. et al. (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2, 29ra31
33. Abu-El-Haija, M., Ramachandran, S., Meyerholz, D. K., Griffin, M., Giriyappa, R. L., Stoltz, D. A., Welsh, M. J., McCray, Jr, P. B. and Uc, A. (2012) Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways. Am. J. Pathol. 181, 499-507
34. Boue, A., Muller, F., Nezelof, C., Oury, J. F., Duchatel, F., Dumez, Y., Aubry, M. C. and Boue, J. (1986) Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis. Hum. Genet. 74, 288-297
35. Imrie, J. R., Fagan, D. G. and Sturgess, J. M. (1979) Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am. J. Pathol. 95, 697-707
36. Oppenheimer, E. H. and Esterly, J. R. (1973) Cystic fibrosis of the pancreas. Morphologic findings in infants with and without diagnostic pancreatic lesions. Arch. Pathol. 96, 149-154
37. Kambara, T. and Govindjee (1985) Molecular mechanism of water oxidation in photosynthesis based on the functioning of manganese in two different environments. Proc. Natl. Acad. Sci. U.S.A. 82, 6119-6123
38. Orci, L., Malaisse-Lagae, F., Baetens, D. and Perrelet, A. (1978) Pancreatic-polypeptide-rich regions in human pancreas. Lancet 2, 1200-1201
39. Kobayashi, K., Kobayashi, N., Okitsu, T., Yong, C., Fukazawa, T., Ikeda, H., Kosaka, Y., Narushima, M., Arata, T. and Tanaka, N. (2004) Development of a porcine model of type 1 diabetes by total pancreatectomy and establishment of a glucose tolerance evaluation method. Artif. Organs 28, 1035-1042
40. Henriksen, J. E., Alford, F., Handberg, A., Vaag, A., Ward, G. M., Kalfas, A. and Beck-Nielsen, H. (1994) Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J. Clin. Invest. 94, 1196-1204
41. Scott, D. A. and Fisher, A. M. (1938) The insulin and the Zinc content of normal and diabetic pancreas. J. Clin. Invest. 17, 725-728
42. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419
43. Porta, E. A., Stein, A. A. and Patterson, P. (1964) Ultrastructural changes of the pancreas and liver in cystic fibrosis. Am. J. Clin. Pathol. 42, 451-465
44. Sturgess, J. M. (1984) Structural and developmental abnormalities of the exocrine pancreas in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 3, S55-S66
45. Tucker, J. A., Spock, A., Spicer, S. S., Shelburne, J. D. and Bradford, W. (2003) Inspissation of pancreatic zymogen material in cystic fibrosis. Ultrastruct. Pathol. 27, 323-335
46. Ornoy, A., Arnon, J., Katznelson, D., Granat, M., Caspi, B. and Chemke, J. (1987) Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis. Am. J. Med. Genet. 28, 935-947
47. Watanabe, H., Sumi, S., Urushihata, T., Kitamura, Y., Iwasaki, S., Xu, G., Yano, S., Nio, Y. and Tamura, K. (2000) Immunohistochemical studies on vascular endothelial growth factor and platelet endothelial cell adhesion molecule-1/CD-31 in islet transplantation. Pancreas 21, 165-173
48. Pour, P. M. and Saruc, M. (2011) The pattern of neural elements in the islets of normal and diseased pancreas and in isolated islets. JOP 12, 395-403
49. Persson-Sjogren, S., Forsgren, S. and Taljedal, I. B. (1998) Expression of tyrosine hydroxylase, calcitonin gene-related peptide, substance P and protein gene product 9.5 in mouse islets transplanted under the kidney capsule. Neuropeptides 32, 307-318
50. Hawkins, K. L., Lloyd, R. V. and Toy, K. A. (1989) Immunohistochemical localization of chromogranin A in normal tissues from laboratory animals. Vet. Pathol. 26, 488-498
51. Hartling, S. G., Garne, S., Binder, C., Heilmann, C., Petersen, W., Petersen, K. E. and Koch, C. (1988) Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test. Diabetes Res. 7, 165-169
52. Lee, A. H., Heidtman, K., Hotamisligil, G. S. and Glimcher, L. H. (2011) Dual and opposing roles of the unfolded protein response regulated by IRE1alpha and XBP1 in proinsulin processing and insulin secretion. Proc. Natl. Acad. Sci. U.S.A. 108, 8885-8890
53. Weir, G. C. and Bonner-Weir, S. (2011) Sleeping islets and the relationship between beta-cell mass and function. Diabetes 60, 2018-2019
54. Shorr, S. S. and Bloom, F. E. (1970) Fine structure of islet-cell innervation in the pancreas of normal and alloxan-treated rats. Z. Zellforsch. Mikrosk. Anat. 103, 12-25
55. Lee, K. M., Cao, D., Itami, A., Pour, P. M., Hruban, R. H., Maitra, A. and Ouellette, M. M. (2007) Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Histopathology 51, 539-546
56. Hardin, D. S., LeBlanc, A., Para, L. and Seilheimer, D. K. (1999) Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 48, 1082-1087
57. Longnecker, D. S. (1982) Pathology and pathogenesis of diseases of the pancreas. Am. J. Pathol. 107, 99-121
58. Zuelzer, W. W. and Newton, Jr, W. A. (1949) The pathogenesis of fibrocystic disease of the pancreas; a study of 36 cases with special reference to the pulmonary lesions. Pediatrics 4, 53-69
59. Lombardo, F., De Luca, F., Rosano, M., Sferlazzas, C., Lucanto, C., Arrigo, T., Messina, M. F., Crisafulli, G., Wasniewska, M., Valenzise, M. and Cucinotta, D. (2003) Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur. J. Endocrinol. 149, 53-59
60. Gentz, J., Persson, B., Kellum, M., Bengtsson, G. and Thorell, J. (1971) Effect of feeding on intravenous glucose tolerance and insulin response in piglets during the first day of life. Life Sci. II 10, 137-144
61. Persson, B., Gentz, J., Kellum, M. and Thorell, J. (1976) Metabolic observations in infants of strictly controlled diabetic mothers. II. Plasma insulin, FFA, glycerol, beta-hydroxybutyrate during intravenous glucose tolerance test. Acta Paediatr. Scand. 65, 1-9
62. Saner, G., Yuksel, T. and Gurson, C. T. (1980) Effect of chromium on insulin secretion and glucose removal rate in the newborn. Am. J. Clin. Nutr. 33, 232-235
63. Stoltz, D. A., Rokhlina, T., Ernst, S. E., Pezzulo, A. A., Ostedgaard, L. S., Karp, P. H., Samuel, M. S., Reznikov, L. R., Rector, M. V., Gansemer, N. D. et al. (2013) Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs. J. Clin. Invest. 123, 2685-2693
64. Sun, X., Sui, H., Fisher, J. T., Yan, Z., Liu, X., Cho, H. J., Joo, N. S., Zhang, Y., Zhou, W., Yi, Y. et al. (2010) Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J. Clin. Invest. 120, 3149-3160
65. Olivier, A. K., Yi, Y., Sun, X., Sui, H., Liang, B., Hu, S., Xie, W., Fisher, J. T., Keiser, N. W., Lei, D. et al. (2012) Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J. Clin. Invest. 122, 3755-3768
66. Abu-El-Haija, M., Sinkora, M., Meyerholz, D. K., Welsh, M. J., McCray, Jr, P. B., Butler, J. and Uc, A. (2011) An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis. Pancreatology 11, 506-515
67. Uc, A., Giriyappa, R., Meyerholz, D. K., Griffin, M., Ostedgaard, L. S., Tang, X. X., Abu-El-Haija, M., Stoltz, D. A., Ludwig, P., Pezzulo, A. et al. (2012) Pancreatic and biliary secretion are both altered in cystic fibrosis pigs. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G961-G968
68. Cucinotta, D., De Luca, F., Arrigo, T., Di Benedetto, A., Sferlazzas, C., Gigante, A., Rigoli, L. and Magazzu, G. (1994) First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance. J. Pediatr. Endocrinol. 7, 13-17
69. Tofe, S., Moreno, J. C., Maiz, L., Alonso, M., Escobar, H. and Barrio, R. (2005) Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur. J. Endocrinol. 152, 241-247
70. Hameed, S., Jaffe, A. and Verge, C. F. (2011) Cystic fibrosis related diabetes (CFRD)-the end stage of progressive insulin deficiency. Pediatr. Pulmonol. 46, 747-760
71. Coriati, A., Belson, L., Ziai, S., Haberer, E., Gauthier, M. S., Mailhot, G., Coderre, L., Berthiaume, Y. and Rabasa-Lhoret, R. (2014) Impact of sex on insulin secretion in cystic fibrosis. J. Clin. Endocrinol. Metab. 99, 1767-1773